CN101731350A - Day and night separated infant milk powder - Google Patents
Day and night separated infant milk powder Download PDFInfo
- Publication number
- CN101731350A CN101731350A CN200910259968A CN200910259968A CN101731350A CN 101731350 A CN101731350 A CN 101731350A CN 200910259968 A CN200910259968 A CN 200910259968A CN 200910259968 A CN200910259968 A CN 200910259968A CN 101731350 A CN101731350 A CN 101731350A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- night
- nucleotides
- weight portion
- baby formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Dairy Products (AREA)
Abstract
The invention relates to infant formula milk powder, in particular to day and night separated infant formula milk powder, belonging to the dairy field. The milk powder comprises sugar, proteins, vitamins, minerals and lipids, which are added by routine technical means. Nucleotide with weight accounting for 0.021-0.056% of the total weight of the product is also added. The product is the daily formula, the nucleotide proportion of which is identical with dynamic variation of the breast milk in the day and at night. The day and night separated infant formula milk powder can be conductive to enhancing the vigor and the immunity, the activity in the day and the sleep quality at night of the infants. The day and night separated infant formula milk powder can provide sufficient nutrition for the infants, help the infants to grow and improve the immunity of the body.
Description
Technical field
The present invention relates to a kind of baby formula milk powder, particularly a kind of day and night divides the open form baby formula milk powder.Belong to field of dairy products.
Background technology
The World Health Organization and United Nations Children's Fund unite and declare that breast milk is baby's a best foods, and any back processing material all can not substitute.Breast milk can satisfy the needs of all physiological nutrition of 4-6 monthly age baby.This reason just, humanized formula becomes the research focus in dispensed food for baby field, in the nutritional labeling of prescription and quantitatively ad infinitum be exactly the direction of research and development near breast milk.
Summary of the invention
The objective of the invention is to obtain a kind of infant's specialized designs at 0 to 3 years old, satisfy on the basis of its required various nutrition of growing in assurance, also satisfy the demand of building up one's resistance to disease on its daytime and satisfy the sleep need at its night according to its physiological activity characteristics.。
Through long term monitoring and observation, find that breast milk is that composition is along with the time constantly changes, it is formed and quantity all is constantly to change in whole lactation period.Nucleotides also is such.Particularly compare, increase significantly in the concentration of the ripe Ruzhong in 15 days postpartum nucleotides with the colostrum in 4-5 days postpartum.In addition, be surprised to find again, five kinds of nucleotides that contain in the breast milk (5 ' adenylate, 5 ' cytidine monophosphate, 5 ' guanylic acid, 5 ' inosinicacid, 5 ' uridylic acid) even concentration neither be stable in one day, it is low to present daytime, the characteristics that night is high.This mainly is because nucleotides has the function of auxiliary infantal sleeping.Characteristics hereto, inventor's exploitation at infant's daytime edible different formula milk have very high realistic meaning.
A kind of day and night of the present invention divides the open form baby formula milk powder, comprise the sugar, proteins,vitamins,minerals, the lipid that adopt the routine techniques means to add, wherein, also be added with the nucleotides that accounts for product gross weight 0.021～0.056%, wherein, described milk powder is divided into two packings, and one is a daily infant milk powder, be night infant milk powder in addition, concrete proportioning is as follows:
The component of daily type oligonucleotide ligand ratio and weight part ratio thereof are for example following:
5 ' adenylate 4-5
5 ' uridylic acid 5-6
5 ' guanylic acid 2.5-3.5
5 ' cytidine monophosphate 4.5-5.5
5 ' inosinicacid 5-6.
The component of above-mentioned nucleotides optimum ratio and weight part ratio thereof are for example following:
5 ' adenylate 4.4
5 ' uridylic acid 5.7
5 ' guanylic acid 3.0
5 ' cytidine monophosphate 5.0
5 ' inosinicacid 5.1.
Wherein, the component of the oligonucleotide ligand of night using type ratio and weight part ratio thereof are for example down:
5 ' adenylate 12-14
5 ' uridylic acid 16-18
5 ' guanylic acid 8-10
5 ' cytidine monophosphate 5-7
5 ' inosinicacid 6-8.
The component of above-mentioned nucleotides optimum ratio and weight part ratio thereof are for example following:
5 ' adenylate 13.2
5 ' uridylic acid 17.1
5 ' guanylic acid 9
5 ' cytidine monophosphate 6
5 ' inosinicacid 7.5.
The component of nucleotides optimum ratio and weight part ratio thereof are for example down in the described daily infant milk formula:
5 ' adenylate 4.4
5 ' uridylic acid 5.7
5 ' guanylic acid 3.0
5 ' cytidine monophosphate 5.0
5 ' inosinicacid 5.1.
The component of nucleotides optimum ratio and weight part ratio thereof are for example down in the described night infant milk formula:
5 ' adenylate 13.2
5 ' uridylic acid 17.1
5 ' guanylic acid 9
5 ' cytidine monophosphate 6
5 ' inosinicacid 7.5.
Also comprise in the above-mentioned milk powder: the DHA of 0.5-1.5% weight portion (7% content pulvis), the ARA of 1-2% weight portion (10% content pulvis).
Also comprise in the above-mentioned milk powder: the choline of 0.05～0.1% weight portion.
Above-mentioned vitamin weight portion is 0.05-0.2%.
Above-mentioned mineral matter weight portion is 0.2-0.5%.
Above-mentioned sugar weight part is 10-30%.
Above-mentioned steamed bun stuffed with sugar is drawn together: white granulated sugar, lactose, FOS, galactooligosaccharide, wherein preferred weight portion percentage is as follows: 0～5%, 5～20%, 0.5～2%, 0.2～2%.
Above-mentioned lipid weight portion is 20-35%.
Above-mentioned lipid comprises: lecithin, vegetable oil, wherein preferred weight portion percentage is as follows: 0.5-0.7% (preferred 0.65%), 5～20%.
In the actual production process, baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 2500～5000kg (amounts to dry 300～600kg); Preferred 3200kg
Desalted whey powder 200～300Kg; Preferred 250kg
WPC 100～200Kg; Preferred 150kg
Carbohydrate 100-300kg, preferred 200kg
Lipid 200～350kg, preferred 130kg
FOS 5～20kg, preferred 12kg
Galactooligosaccharide 2～20kg, preferred 10kg
Nucleotides 0.21～0.56kg, preferred 0.35kg
Choline 0.5～1kg, preferred 0.8kg
Vitamin premix 2-5kg, preferred 2.5kg
Mineral substance premix 2-5kg, preferred 4kg
DHA 5-15kg, preferred 8kg
ARA 10-20kg, preferred 16kg.
Above-mentioned milk is full-cream nonreactive fresh milk or milk powder.
The composition of vitamin premix and part by weight are: vitamin A 1165.5-4224.1IU, vitamin D
3250-885IU, vitamin E 12.5-35.4IU, vitamin C 62.5-221.25mg, vitamin K 25-177 μ g, Cobastab
1350-2124 μ g, Cobastab
2475-2802.5 μ g, Cobastab
6225-1239 μ g, Cobastab
120.625-3.54 μ g, nicotinic acid 1.8-11.06mg, pantothenic acid 2375-14012.5 μ g, folic acid 62.5-354 μ g, biotin 10-53.1 μ g.
The composition of mineral substance premix and part by weight are: calcium 300-973.5mg, phosphorus 150-649mg, magnesium 30-106.2mg, potassium 375-1121mg, iron 3.5-14.75mg, zinc 3-10.62mg, sodium 125-413mg, iodine 62.5-354 μ g, copper 210-737.5 μ g, manganese 6.25-737.5 μ g.
In concrete production process, the material purity that has not is the product of 100% scale, need convert according to the active principle percentage composition on the raw material label of reality.For example, need to add certain material of 10 grams in the above-mentioned prescription of the present invention, but the purity of raw material is 50%, the consumption of raw material then is 20 grams so.
Technological progress characteristics of the present invention show:
1. finished product is mixing of daily prescription and ight prescription, and the dynamic change on their nucleotide proportion and breast milk daytime matches.
2. day and night branch open form prescription can help the infant to invigorate and resistance.
3. can help it to grow for the infant provides sufficient nutrition, improve the resistance of body.
The specific embodiment
Embodiment 1
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 5000kg;
Desalted whey powder 300Kg;
WPC 200Kg;
Carbohydrate 300kg
Lipid 350kg
FOS 20kg
Galactooligosaccharide 20kg
Nucleotides 0.56kg
Choline 1kg
Vitamin premix 5kg
Mineral substance premix 5kg
DHA 15kg
ARA 20kg
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate 5
5 ' uridylic acid 6
5 ' guanylic acid 3.5
5 ' cytidine monophosphate 5.5
5 ' inosinicacid 6.
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 13.2
5 ' uridylic acid 17.1
5 ' guanylic acid 9
5 ' cytidine monophosphate 6
5 ' inosinicacid 7.5.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 2
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 2500kg
Desalted whey powder 200Kg;
WPC 100Kg;
Carbohydrate 100kg
Lipid 200 130kg
FOS 5kg
Galactooligosaccharide 2kg
Nucleotides 0.21kg
Choline 0.5kg
Vitamin premix 2kg
Mineral substance premix 2kg
DHA 5kg
ARA 10kg。
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate 4
5 ' uridylic acid 5
5 ' guanylic acid 2.5
5 ' cytidine monophosphate 4.5
5 ' inosinicacid 5.
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 12
5 ' uridylic acid 16
5 ' guanylic acid 8
5 ' cytidine monophosphate 5
5 ' inosinicacid 6.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 3
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 3200kg
Desalted whey powder 250Kg;
WPC 150Kg;
Carbohydrate 200kg
Lipid 130kg
FOS 12kg
Galactooligosaccharide 10kg
Nucleotides 0.35kg
Choline 0.8kg
Vitamin premix 2.5kg
Mineral substance premix 4kg
DHA 8kg
ARA 16kg。
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate (5 ' AMP) 4.4
5 ' uridylic acid (5 ' UMP) 5.7
5 ' guanylic acid (5 ' GMP) 3.0
5 ' cytidine monophosphate (5 ' CMP) 5.0
5 ' inosinicacid (5 ' IMP) 5.1
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 14
5 ' uridylic acid 18
5 ' guanylic acid 10
5 ' cytidine monophosphate 7
5 ' inosinicacid 7.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 4
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 2500kg
Desalted whey powder 300Kg;
WPC 100Kg;
Carbohydrate 200kg
Lipid 350kg
FOS 12kg
Galactooligosaccharide 20kg
Nucleotides 0.21kg
Choline 0.8kg
Vitamin premix 5kg
Mineral substance premix 4kg
DHA 5kg
ARA 20kg。
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate 5
5 ' uridylic acid 5
5 ' guanylic acid 3
5 ' cytidine monophosphate 5
5 ' inosinicacid 5.
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 12
5 ' uridylic acid 16
5 ' guanylic acid 10
5 ' cytidine monophosphate 5
5 ' inosinicacid 7.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 5
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 5000kg
Desalted whey powder 200Kg;
WPC 200Kg;
Carbohydrate 200kg
Lipid 200 130kg
FOS 5kg
Galactooligosaccharide 20kg
Nucleotides 0.21kg
Choline 0.8kg
Vitamin premix 2.5kg
Mineral substance premix 4kg
DHA 8kg
ARA 16kg。
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate 4
5 ' uridylic acid 6
5 ' guanylic acid 2.5
5 ' cytidine monophosphate 5.5
5 ' inosinicacid 5.
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 13.2
5 ' uridylic acid 16
5 ' guanylic acid 9
5 ' cytidine monophosphate 6
5 ' inosinicacid 7.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 6
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 5000kg;
Desalted whey powder 200Kg;
WPC 200Kg;
Carbohydrate 200kg
Lipid 200kg
FOS 20kg
Galactooligosaccharide 10kg
Nucleotides 0.21kg
Choline 1kg
Vitamin premix 2.5kg
Mineral substance premix 2kg
DHA 15kg
ARA 16kg。
The weight part ratio of wherein daily type nucleotides is for example following:
5 ' adenylate 4.5
5 ' uridylic acid 5
5 ' guanylic acid 3.5
5 ' cytidine monophosphate 5
5 ' inosinicacid 5.
Wherein the weight part ratio of night using type nucleotides is for example down:
5 ' adenylate 14
5 ' uridylic acid 18
5 ' guanylic acid 10
5 ' cytidine monophosphate 7
5 ' inosinicacid 8.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
Embodiment 7
Baby formula milk powder of the present invention, the component and the part by weight of needed raw material are as follows:
Milk 5000kg
Desalted whey powder 200Kg;
WPC 200Kg;
Carbohydrate 300kg
Lipid 200kg
FOS 12kg
Galactooligosaccharide 10kg
Nucleosides 0.21kg
Choline 0.8kg
Vitamin premix 2.5kg
Mineral substance premix 2kg
DHA 5kg
ARA 10kg。
Wherein the weight part ratio of nucleotides is for example down:
5 ' adenylate 13
5 ' uridylic acid 17
5 ' guanylic acid 8
5 ' cytidine monophosphate 7
5 ' inosinicacid 7.
Above-mentioned raw materials is mixed, after through pasteurize, homogeneous, evaporation and concentration is spray dried to milk powder.
The result of invention
Though below done to elaborate according to the design and the embodiment of the object of the invention; but those of ordinary skills can recognize; under the precondition that does not break away from the claim limited range; still can make various improvement and conversion to the present invention, and these improve and conversion still should belong to protection scope of the present invention.
The effect of product of the present invention is as follows:
Product of the present invention has carried out the animal experiments such as acute toxicity test, genetic toxicity test, 30 days feeding trials, traditional teratogenicity test, proves that this product safety is nontoxic; Has simultaneously the effect that promotes mouse growth.
Select 300 routine babies of in October, 2008-2009 year birth in February to test, wherein boy baby's 150 examples, girl baby's 150 examples. These babies are mature first tire, and BWt is at 2.91-3.32kg, and height is at 49-52cm. No any disease in 0-30 days. The baby group that monthly age is identical, object is fed in the conduct of height, body weight, head circumference no difference of science of statistics. Father and mother are supporter or volunteers of this plan. Two groups of infants' educational level of parents and family economic status aspect no difference of science of statistics. The baby of screening does not belong to lactose intolerance, lactoprotein inadaptation crowd.
According to experimental design, be divided into boy baby's group and girl baby's group, each group is divided into again common baby milk nursing group, infant formula nursing group of the present invention.
The feeding volume of table 1 suggestion
| Average weight | Feeding volume | ||
| Monthly age | kg | ml | 24h feeds number of times |
| 8 months | 8.5 | 230 | 5 |
| 10 months | 9.2 | 240 | 5 |
| 12 months | 9.7 | 250 | 4 |
Different feeding mode and physical growth of infants the results are shown in Table 2.
Table 2 feeding patterns and physical growth of infants be x ± s as a result
The state evaluation and test (every group of 150 examples) on 300 routine baby daytimes:
| Grouping | Flu percentage | The mean activity time on daytime (8-19 point) |
| Common baby milk nursing group | 0.33％ | 7.26 hour |
| Infant formula | 0.04％ | 7.86 hour |
The state evaluation and test (every group of 150 examples) at 300 routine baby nights:
| Grouping | Flu percentage | The average length of one's sleep at night (19 points-second day 8 points) |
| Common baby milk nursing group | 0.33％ | 9.26 hour |
| Infant formula | 0.04％ | 10.86 hour |
Claims (10)
1. a day and night divides the open form baby formula milk powder, comprise the sugar, proteins,vitamins,minerals, the lipid that adopt the routine techniques means to add, it is characterized in that: also be added with the nucleotides that accounts for product gross weight 0.021～0.056%, wherein, described milk powder is divided into two packings, one is a daily infant milk powder, is night infant milk powder in addition, and concrete proportioning is as follows:
The component of nucleotides proportioning and weight part ratio thereof are for example down in the described daily infant milk formula:
5 ' adenylate 4-5
5 ' uridylic acid 5-6
5 ' guanylic acid 2.5-3.5
5 ' cytidine monophosphate 4.5-5.5
5 ' inosinicacid 5-6;
The component of nucleotides proportioning and weight part ratio thereof are for example down in the described night infant milk formula:
5 ' adenylate 12-14
5 ' uridylic acid 16-18
5 ' guanylic acid 8-10
5 ' cytidine monophosphate 5-7
5 ' inosinicacid 6-8.
2. baby formula milk powder as claimed in claim 1 is characterized in that:
The component of nucleotides optimum ratio and weight part ratio thereof are for example down in the described daily infant milk formula:
5 ' adenylate 4.4
5 ' uridylic acid 5.7
5 ' guanylic acid 3.0
5 ' cytidine monophosphate 5.0
5 ' inosinicacid 5.1.
The component of nucleotides optimum ratio and weight part ratio thereof are for example down in the described night infant milk formula:
5 ' adenylate 13.2
5 ' uridylic acid 17.1
5 ' guanylic acid 9
5 ' cytidine monophosphate 6
5 ' inosinicacid 7.5.
3. baby formula milk powder as claimed in claim 1 is characterized in that: also comprise in the described milk powder: the DHA of 0.5-1.5% weight portion, the ARA of 1-2% weight portion.
4. baby formula milk powder as claimed in claim 1 is characterized in that: also comprise in the described milk powder: the choline of 0.05～0.1% weight portion.
5. baby formula milk powder as claimed in claim 1 is characterized in that: described vitamin weight portion is 0.05-0.2%.
6. baby formula milk powder as claimed in claim 1 is characterized in that: described mineral matter weight portion is 0.2-0.5%.
7. baby formula milk powder as claimed in claim 1 is characterized in that: described sugar weight part is 10-30%.
8. baby formula milk powder as claimed in claim 7, it is characterized in that: described steamed bun stuffed with sugar is drawn together: white granulated sugar, lactose, FOS, galactooligosaccharide, wherein preferred weight portion percentage is as follows: 0～5%, 5～20%, 0.5～2%, 0.2～2%.
9. baby formula milk powder as claimed in claim 1 is characterized in that: described lipid weight portion is 20-35%.
10. baby formula milk powder as claimed in claim 9 is characterized in that: described lipid comprises: lecithin, vegetable oil, and wherein preferred weight portion percentage is as follows:
0.5-0.7% (preferred 0.65%), 5～20%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910259968A CN101731350A (en) | 2009-12-24 | 2009-12-24 | Day and night separated infant milk powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910259968A CN101731350A (en) | 2009-12-24 | 2009-12-24 | Day and night separated infant milk powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101731350A true CN101731350A (en) | 2010-06-16 |
Family
ID=42455766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910259968A Pending CN101731350A (en) | 2009-12-24 | 2009-12-24 | Day and night separated infant milk powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101731350A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103168839A (en) * | 2011-12-22 | 2013-06-26 | 浙江贝因美科工贸股份有限公司 | Preparation process of infant formula milk powder |
| CN106720372A (en) * | 2016-11-23 | 2017-05-31 | 光明乳业股份有限公司 | A kind of children's prescription emulsifiable powder, children's prescription emulsifiable powder suit and the preparation method of the two |
| CN109619566A (en) * | 2019-01-22 | 2019-04-16 | 广州硕维食品技术有限公司 | A kind of nutraceutical for alleviating asthenopia |
| CN110623073A (en) * | 2019-10-15 | 2019-12-31 | 卜球 | Formula milk powder beneficial to body height and preparation method thereof |
-
2009
- 2009-12-24 CN CN200910259968A patent/CN101731350A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103168839A (en) * | 2011-12-22 | 2013-06-26 | 浙江贝因美科工贸股份有限公司 | Preparation process of infant formula milk powder |
| CN106720372A (en) * | 2016-11-23 | 2017-05-31 | 光明乳业股份有限公司 | A kind of children's prescription emulsifiable powder, children's prescription emulsifiable powder suit and the preparation method of the two |
| CN106720372B (en) * | 2016-11-23 | 2020-06-30 | 光明乳业股份有限公司 | Children formula milk powder, children formula milk powder set and preparation methods of children formula milk powder and children formula milk powder set |
| CN109619566A (en) * | 2019-01-22 | 2019-04-16 | 广州硕维食品技术有限公司 | A kind of nutraceutical for alleviating asthenopia |
| CN110623073A (en) * | 2019-10-15 | 2019-12-31 | 卜球 | Formula milk powder beneficial to body height and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038041B (en) | Mineral substance formula milk powder for infants | |
| CN101427789A (en) | Liquid milk with additive nucleotide suitable for baby of 12 to 36 months old | |
| CN102524422B (en) | Infant formula milk powder containing alpha-lactalbumin and lactoferrin and preparation method for infant formula milk powder | |
| CN101011088A (en) | Finite baby meal | |
| CN101427798A (en) | Liquid milk with additive nucleotide suitable for baby of 0 to 6 months old | |
| CN101427794A (en) | Liquid milk with additive nucleotide suitable for baby of 6 to 12 months old | |
| CN105532919A (en) | Total-nutrition formulated milk powder for children and preparation method thereof | |
| CN101731350A (en) | Day and night separated infant milk powder | |
| CN101313704A (en) | Liquid milk for baby of birth time to 12 months ages and method using online addition technique | |
| CN101313700B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method of injection type direct disinfection | |
| CN101218942B (en) | Serum albumin added liquid condition milk for baby | |
| CN101313702B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method with ejection type direct disinfection | |
| CN101731351A (en) | Daily infant formula milk powder | |
| CN101731356A (en) | Night infant formula milk powder | |
| CN101313699B (en) | Liquid milk for baby of 12 to 36 months ages and preparation method for injection type direct disinfection | |
| CN101317609B (en) | Liquid milk with additive serum albumin for baby of 6 to 12 months age | |
| CN101317596B (en) | Liquid milk for baby of 12 to 36 months age and method for using on-line addition technique thereof | |
| CN101317597B (en) | Liquid milk for baby of birth to 6 months age and preparation method of spray type direct disinfection | |
| CN102406102B (en) | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies | |
| CN101313701B (en) | Liquid milk for baby of 6 to 12 months age | |
| CN101313703B (en) | Liquid milk for baby of 12 to 36 months age and preparation method with ejection type direct disinfection | |
| CN101313712B (en) | Liquid milk with additive lactose suitable for baby of 12 to 36 months ages | |
| CN101361508B (en) | Liquid milk added with mineral matter suitable for 12-36 month baby | |
| CN101313708B (en) | Liquid milk with additive carbohydrate suitable for baby of 6 to 12 months ages | |
| CN104705562A (en) | Fortified calcium nutrient rice flour |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100616 |